Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 2Pancreatic Cystic Neoplasm 1Gastrointestinal Stromal Tumor of Stomach 1Esophageal Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Gemcitabine 58130-nm albumin-bound paclitaxel 35Specimen Handling 26Fluorouracil 22Albumin-Bound Paclitaxel 22Magnetic Resonance Spectroscopy 21Leucovorin 21Irinotecan 21Oxaliplatin 19Biopsy 17Taxes 16pembrolizumab 15Cyclophosphamide 12Cisplatin 11fludarabine 10Cetuximab 9Capecitabine 8durvalumab 7Radiosurgery 7Nivolumab 7Carboplatin 7irinotecan sucrosofate 6dehydroftorafur 6Pemetrexed 6olaparib 5Radiotherapy 5Ipilimumab 5Erlotinib Hydrochloride 5Blood Specimen Collection 5trastuzumab deruxtecan 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pancreatic Neoplasms × Endoscopic Ultrasound-Guided Fine Needle Aspiration × 90 days × Clear all
NCT04239573 2026-05-27

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Eastern Cooperative Oncology Group

Phase NA Recruiting
770 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT05961982 2026-03-23

ERASE

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
84 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡